Published in J Urol on February 01, 2005
Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev (2010) 5.83
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Clinical implications and utility of field cancerization. Cancer Cell Int (2007) 1.91
Telomerase and its potential for therapeutic intervention. Br J Pharmacol (2007) 1.11
Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discov (2013) 1.03
Markers of field cancerization: proposed clinical applications in prostate biopsies. Prostate Cancer (2012) 1.00
Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer. Neoplasia (2007) 1.00
Prognostic determinants in prostate cancer. Cancer J (2011) 0.95
Influence of mindfulness-based stress reduction (MBSR) on telomerase activity in women with breast cancer (BC). Biol Res Nurs (2014) 0.92
Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer. PLoS One (2013) 0.90
Organ-wide telomeric status in diseased and disease-free prostatic tissues. Prostate (2010) 0.90
Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate (2011) 0.89
Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer. Urology (2009) 0.89
Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma. PLoS One (2014) 0.86
Prostate cancer: the need for biomarkers and new therapeutic targets. J Zhejiang Univ Sci B (2014) 0.82
Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer. Int J Cancer (2016) 0.78
Potential clinical role of telomere length in human glioblastoma. Transl Med UniSa (2011) 0.78
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas. Cancer Med (2012) 0.77
Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence. Prostate Cancer Prostatic Dis (2015) 0.76
Correlations of telomere length, P53 mutation, and chromosomal translocation in soft tissue sarcomas. Int J Clin Exp Pathol (2015) 0.76
Dynamic length changes of telomeres and their nuclear organization in chronic myeloid leukemia. Cancers (Basel) (2013) 0.75
For cancers there is more to life than a longer G-strand. Asian J Androl (2010) 0.75
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate (2015) 0.75
Telomere length modulation in human astroglial brain tumors. PLoS One (2013) 0.75
Tracking the clonal origin of lethal prostate cancer. J Clin Invest (2013) 5.79
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget (2012) 3.88
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst (2009) 3.77
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc Natl Acad Sci U S A (2011) 2.12
Randomized evaluation of a web based interview process for urology resident selection. J Urol (2012) 1.95
GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol (2007) 1.89
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol (2006) 1.79
Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Am J Kidney Dis (2009) 1.66
GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol (2009) 1.63
Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol (2006) 1.61
Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls. Cancer (2004) 1.60
Telomere length as a risk factor for hereditary prostate cancer. Prostate (2013) 1.50
A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer (2012) 1.47
Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis (2006) 1.45
Telomeres: prognostic markers for solid tumors. Int J Cancer (2006) 1.44
Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer (2003) 1.44
Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis (2004) 1.44
Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat (2009) 1.40
Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev (2003) 1.37
Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull (2009) 1.32
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med (2003) 1.30
Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat (2006) 1.27
Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer (2006) 1.25
Effects of misattribution in assigning cause of death on prostate cancer mortality rates. Ann Epidemiol (2003) 1.25
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors. Gynecol Oncol (2009) 1.21
Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? J Am Soc Nephrol (2007) 1.15
Age-related blood pressure patterns and blood pressure variability among hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.13
TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis (2005) 1.11
Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma. Arch Pathol Lab Med (2005) 1.09
Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer (2011) 1.09
Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine. J Virol (2002) 1.08
A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiol Biomarkers Prev (2013) 1.08
Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain Behav Immun (2012) 1.07
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol (2012) 1.06
Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol (2012) 1.04
Are drunk-driving offenders referred for screening accurately reporting their drug use? Drug Alcohol Depend (2002) 1.02
Accuracy of alcohol diagnosis among DWI offenders referred for screening. Drug Alcohol Depend (2004) 1.01
Ethnic differences in the use of complementary and alternative therapies among adults with osteoarthritis. Prev Chronic Dis (2006) 1.01
Markers of field cancerization: proposed clinical applications in prostate biopsies. Prostate Cancer (2012) 1.00
Limb hyperplasia: case report of an unusual variant of Klippel-Trenaunay syndrome and review of the literature. Cutis (2009) 0.99
The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression. Mod Pathol (2009) 0.96
Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells. Int J Cancer (2013) 0.94
Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am J Trop Med Hyg (2009) 0.93
Prostate-specific antigen testing accuracy in community practice. BMC Fam Pract (2002) 0.92
Telomere DNA content predicts breast cancer-free survival interval. Clin Cancer Res (2007) 0.91
Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol (2002) 0.91
Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues. Mol Cancer Res (2005) 0.90
Organ-wide telomeric status in diseased and disease-free prostatic tissues. Prostate (2010) 0.90
Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate (2011) 0.89
Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer. Urology (2009) 0.89
Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. Mod Pathol (2010) 0.89
Chemiluminescent measurement of telomere DNA content in biopsies. Biotechniques (2002) 0.89
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States. Int J Cancer (2014) 0.88
Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Ann Intern Med (2015) 0.87
Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. Am J Med (2006) 0.87
Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955. J Urol (2004) 0.87
Protease nexin-1 expression is altered in human breast cancer. Cancer Cell Int (2006) 0.87
Collection and characterisation of bacterial membrane proteins. FEBS Lett (2003) 0.87
A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma. J Urol (2005) 0.87
Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management. Int J Cancer (2014) 0.87
Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer. J Infect Dis (2008) 0.84
Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstet Gynecol (2016) 0.84
A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model. Mol Cell Biochem (2006) 0.84
Invasive pulmonary mucormycosis with ruptured pseudoaneurysm. Ann Thorac Surg (2003) 0.84
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol (2012) 0.84
Genomic instability demonstrates similarity between DCIS and invasive carcinomas. Breast Cancer Res Treat (2008) 0.84
No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. J Infect Dis (2013) 0.83
p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum Pathol (2005) 0.82
A glioblastoma neurosphere line with alternative lengthening of telomeres. Acta Neuropathol (2013) 0.82
Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor adjacent, histologically normal breast tissue. Mol Cancer Res (2011) 0.82
Cervical histopathology variability among laboratories: a population-based statewide investigation. Am J Clin Pathol (2013) 0.82
Concurrence of multiple human papillomavirus infections in a large US population-based cohort. Am J Epidemiol (2014) 0.82
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer. Prostate (2008) 0.81
SEER coding standards result in underestimation of positive surgical margin incidence at radical prostatectomy: results of a systematic audit. J Urol (2011) 0.81
Psychiatric disorders of convicted DWI offenders: a comparison among Hispanics, American Indians and non-Hispanic whites. J Stud Alcohol (2004) 0.80
Relationships of clinic size, geographic region, and race/ethnicity to the frequency of missed/shortened dialysis treatments. J Nephrol (2014) 0.80
Assessment of the frequency of allelic imbalance in human tissue using a multiplex polymerase chain reaction system. J Mol Diagn (2007) 0.79
Prostate cancer testing following a negative prostate biopsy: over testing the elderly. J Gen Intern Med (2007) 0.78
What we have learned from randomized trials of prostate cancer screening. Asian J Androl (2011) 0.78